SMS Co., Ltd. (TYO:2175)
Japan
· Delayed Price · Currency is JPY 1,213.50
-5.50 (-0.45%)
Mar 12, 2025, 3:30 PM JST
SMS Co., Ltd. Revenue
SMS Co., Ltd. had revenue of 13.04B JPY in the quarter ending December 31, 2024, with 9.76% growth. This brings the company's revenue in the last twelve months to 59.50B, up 15.33% year-over-year. In the fiscal year ending March 31, 2024, SMS Co., Ltd. had annual revenue of 53.97B with 18.19% growth.
Revenue (ttm)
59.50B
Revenue Growth
+15.33%
P/S Ratio
1.75
Revenue / Employee
14.21M
Employees
4,188
Market Cap
103.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 53.97B | 8.31B | 18.19% |
| Mar 31, 2023 | 45.67B | 6.77B | 17.40% |
| Mar 31, 2022 | 38.90B | 2.94B | 8.17% |
| Mar 31, 2021 | 35.96B | 820.00M | 2.33% |
| Mar 31, 2020 | 35.14B | 4.30B | 13.96% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Otsuka Holdings | 2,329.86B |
| Terumo | 1,011.15B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |